Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Oligometastatic Prostate Cancer (OMPC) × Lutetium-177 × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 9 Urogenital Neoplasms 1 Prostatic Diseases 1 Prostate Cancer Metastatic 1 Oligometastatic Prostate Cancer (OMPC) 1 Neoplasm Metastasis 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Biochemically Recurrent Prostate Carcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05939414 2026-02-24

PSMA-DC

Novartis

Phase 3 Recruiting

Oligometastatic Prostate Cancer (OMPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡